Nanoparticles have unexpected properties and are an area of research for biomedical, electronic and optics applications. Cellix developed a novel microfluidic biochip and assay to allow researchers to investigate cellular uptake of nanoparticles in endothelial cells under defined flow rates like those found in vivo.

To understand asthma and be able to treat it more effectively, researchers need to know how pro-inflammatory eosinophils move from the lungs into surrounding tissue and cause damage. The technology Cellix developed aims to answer these questions, and help identify leads for drug candidates earlier. 

In 'living photonics', researchers aim to diagnose cardiovascular disease with cells in a dish, by interrogating the cells with light and comparing diseased and healthy cells. To allow this, Cellix developed an advanced, enclosed, microfluidics-based system for real time monitoring of cell cultures.